Skip to main content

Table 5 Univariate and multivariate Cox proportional hazard regression analysis for No-DM patients

From: Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Clinical outcomes (n, %)

Univariate multivariate

HR (95% CI)

P

HR (95% CI)

P

MACE

1.190 (0.976–1.451)

0.085

1.145 (0.937–1.401)

0.186

All-cause death

1.477 (0.827–2.637)

0.188

1.268 (0.686–2.344)

0.449

Cardiac death

0.886 (0.363–2.159)

0.790

0.772 (0.293–2.039)

0.602

Non-fatal MI

0.834 (0.493–1.413)

0.50

0.758 (0.441–1.304)

0.317

Stent thrombosis

0.692 (0.289–1.654)

0.407

0.573 (0.222–1.480)

0.250

Revascularization

1.188 (0.936–1.508)

0.157

1.184 (0.931–1.505)

0.168

TVR

1.619 (1.193–2.198)

0.002

1.539 (1.128–2.099)

0.007

TLR

2.109 (1.501–2.963)

< 0.001

1.963 (1.390–2.772)

< 0.001

Stroke

1.087 (0.611–1.932)

0.778

0.976 (0.538–1.771)

0.936

Bleeding

1.022 (0.798–1.310)

0.861

1.055 (0.807–1.379)

0.696

 BRAC 2_5

0.927 (0.625–1.374)

0.705

0.929 (0.625–1.381)

0.714

 BRAC 3_5

0.613 (0.213–1.766)

0.364

0.630 (0.216–1.839)

0.397

  1. DM diabetes mellitus, G2-DES second generation drug-eluting stent, BP-DES biodegradable polymer drug-eluting stent, MACE major adverse cardiac events, MI myocardial infarction, TVR target vessel revascularization, BARC Bleeding Academic Research Consortium definition